journal article·2025-03

Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer

Yunlong Li, Zhiyuan Liu, Ping Wang, Xuerong Gu, Fei Ling, Jiayuan Zhong, Dong Yin, Rui Liu, Xueqing Yao, Chengzhi Huang

Advanced Healthcare Materials· Volume 14· Issue 6
Publisher page

Abstract

Abstract Oxaliplatin (OXA) is the first‐line drug for the treatment of colorectal cancer (CRC), and susceptibility to drug resistance affects patient prognosis. However, the exact underlying mechanisms remain unclear. Platinum‐acquired resistance in CRC is a continuous transition process; though, current research has mainly focused on the end state of drug resistance, and the early events of drug resistance have been ignored. In this study, single‐cell transcriptome sequencing is combined with a dynamic network biomarker (DNB), and found that the functional inhibition of the mitochondrial electron transport chain complex I occur early in the development of attained resistance to OXA in CRC cells, as evidenced by a decrease in the levels of subunit proteins, primarily NDUFB8. Specifically, the mouse double minute 2 homologue (MDM2) mediates the ubiquitination and degradation of NDUFB8, reducing intracellular reactive oxygen species (ROS) generation under chemotherapeutic stress, consequently contributing to drug resistance. Based on this, the study constructs engineered extracellular vesicles carrying siMDM2 by electroporation and validates the application of EV‐siMDM2 to improve the efficacy of OXA‐based chemotherapy by inhibiting the MDM2/NDUFB8/ROS signaling axis in patient‐derived xenograft (PDX) and hepatic and pulmonary metastasis mouse models, thus providing new ideas and an experimental basis for the platinum‐resistant treatment of CRC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510000 China

Department of Gastroenterology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510000 China

Department of Gastrointestinal Surgery Department of General Surgery Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Southern Medical University Guangzhou 510000 China

The Second School of Clinical Medicine Southern Medical University Guangzhou 510000 China

Department of General Surgery Guangdong Provincial People's Hospital Ganzhou Hospital (Ganzhou Municipal Hospital) Ganzhou 341000 China

School of Biology and Biological Engineering South China University of Technology Guangzhou 510006 China

School of Mathematics and Big Data Foshan Univerisity Foshan 528000 China

Guangdong‐Hong Kong Joint Laboratory for RNA Medicine Research Center of Medicine Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou 510000 China

School of Mathematics South China University of Technology Guangzhou 510006 China

School of Medicine South China University of Technology Guangzhou 510640 China

Funding

Natural Science Foundation of Guangdong Province · National Natural Science Foundation of China

References (45)

Show source-provided references
1. 10.3322/caac.2183410.3322/caac.21834 ↗
2. 10.3322/caac.2173110.3322/caac.21731 ↗
3. 10.3322/caac.2170810.3322/caac.21708 ↗
4. 10.1016/S0140-6736(10)60353-410.1016/S0140-6736(10)60353-4 ↗
5. 10.2174/011381612827474223110306373810.2174/0113816128274742231103063738 ↗
6. 10.2174/092986732466617011115243610.2174/0929867324666170111152436 ↗
7. 10.1001/jama.2021.010610.1001/jama.2021.0106 ↗
8. 10.1038/nrc216710.1038/nrc2167 ↗
9. 10.1155/2018/341207410.1155/2018/3412074 ↗
10. 10.3389/fimmu.2020.0138710.3389/fimmu.2020.01387 ↗
11. 10.2217/pgs-2021-011610.2217/pgs-2021-0116 ↗
12. 10.3748/wjg.v24.i34.383410.3748/wjg.v24.i34.3834 ↗
13. 10.7150/thno.6942410.7150/thno.69424 ↗
14. 10.1186/s12967-017-1320-710.1186/s12967-017-1320-7 ↗
15. 10.1016/j.csbj.2022.02.01910.1016/j.csbj.2022.02.019 ↗
16. 10.1038/s41467-018-03024-210.1038/s41467-018-03024-2 ↗
17. 10.1016/j.csbj.2023.09.03010.1016/j.csbj.2023.09.030 ↗
18. 10.1186/s12967-022-03445-010.1186/s12967-022-03445-0 ↗
19. 10.1093/jmcb/mjy05910.1093/jmcb/mjy059 ↗
20. 10.1126/science.aau697710.1126/science.aau6977 ↗
21. 10.1038/nrd397810.1038/nrd3978 ↗
22. 10.1021/acs.chemrev.7b0053410.1021/acs.chemrev.7b00534 ↗
23. 10.1016/j.critrevonc.2022.10362810.1016/j.critrevonc.2022.103628 ↗
24. 10.1021/acsbiomaterials.2c0132910.1021/acsbiomaterials.2c01329 ↗
25. 10.1007/s10787-022-01115-710.1007/s10787-022-01115-7 ↗
26. 10.7150/thno.3970610.7150/thno.39706 ↗
27. 10.1016/j.actbio.2023.09.02310.1016/j.actbio.2023.09.023 ↗
28. 10.3390/molecules2721728910.3390/molecules27217289 ↗
29. 10.1021/acsbiomaterials.3c0074510.1021/acsbiomaterials.3c00745 ↗
30. 10.1088/1748-605X/ad331010.1088/1748-605X/ad3310 ↗
31. 10.1038/s41580-021-00415-010.1038/s41580-021-00415-0 ↗
32. 10.1146/annurev-biochem-070511-10370010.1146/annurev-biochem-070511-103700 ↗
33. 10.3390/antiox808028510.3390/antiox8080285 ↗
34. 10.1038/s41580-022-00456-z10.1038/s41580-022-00456-z ↗
35. 10.1016/j.drup.2018.11.00110.1016/j.drup.2018.11.001 ↗
36. 10.1016/j.drup.2022.10084410.1016/j.drup.2022.100844 ↗
37. 10.7150/ijbs.6660210.7150/ijbs.66602 ↗
38. 10.1038/cr.2016.3910.1038/cr.2016.39 ↗
39. 10.1038/s41467-017-00299-910.1038/s41467-017-00299-9 ↗
40. 10.1038/s41375-020-0949-z10.1038/s41375-020-0949-z ↗
41. 10.1186/s13045-022-01314-310.1186/s13045-022-01314-3 ↗
42. 10.1016/j.molcel.2018.01.02310.1016/j.molcel.2018.01.023 ↗
43. 10.1016/j.molcel.2019.02.01210.1016/j.molcel.2019.02.012 ↗
44. 10.1016/j.ajps.2017.07.00810.1016/j.ajps.2017.07.008 ↗
45. 10.1186/s12951-022-01472-z10.1186/s12951-022-01472-z ↗